Cure My Disease

Don't miss your cure!

 Log in / Sign up

COPD may affect the brain and muscles, not just the lungs

NCT ID NCT07825636

Knowledge-focused Sponsor: Alanya Alaaddin Keykubat University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 17, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

Researchers are studying how chronic obstructive pulmonary disease (COPD) relates to sensorimotor function, thinking skills, pain sensitivity, and muscle quality. The study compares adults aged 40 to 65 with COPD at different disease stages against healthy adults of the same age. Participants complete tests of cognition, pain threshold, muscle quality, and lower extremity coordination. The goal is to understand whether functional differences exist between people with COPD and healthy controls, and whether those differences track with disease stage.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If researchers find clear links between COPD stage and sensorimotor decline, that could shape rehabilitation programs and monitoring for people with the disease.
What could go wrong
This is an observational study with 95 participants, so it can show associations but not prove cause and effect. Results may not apply to people with COPD who have other major health conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

95 people

The number who actually took part.

Started

Oct 2024

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals diagnosed with COPD or healthy controls between the age of 40-65 years.

Ages

40 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Individuals diagnosed with COPD, * Aged 40-65 years, who volunteer to participate in the study, * Who do not have additional musculoskeletal disorders, neurological or cardiorespiratory problems, or respiratory failure (not using long-term home oxygen therapy or non-invasive mechanical ventilation) will be included. Inclusion Criteria for Healthy Individuals: * Individuals aged 40-65 years who volunteer to participate in the study, * Who do not have additional musculoskeletal disorders, neurological or cardiorespiratory problems, * Who do not have communication problems will be included. Exclusion Criteria: Exclusion Criteria for Individuals with COPD * Individuals with uncorrected visual and hearing impairment, * Individuals with a diagnosed serious chronic disease (neurological disease, cancer, chronic heart failure, etc.). Exclusion Criteria for Healthy Individuals * Individuals with uncorrected visual and hearing impairment, * A diagnosed serious chronic disease (neurological disease, cancer, chronic heart failure, etc.) will be excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease (COPD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease Cognitive Dysfunction Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic obstructive pulmonary disease (COPD)

Contacts and locations

Locations

  • Alanya Alaaddin Keykubet University

    Antalya, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.